✨ Reassessment of Registered Trade Name Products
NEW ZEALAND GAZETTE, No. 72 — 18 AUGUST 2016
Trade Name: Intercept
Reference: A010540
Active Ingredients and Concentrations:
- Bismuth subnitrate 2.6g per 4.0g syringe
- Chlorhexidine 20mg per 4.0g syringe
Formulation Type: Intramammary suspension
General Use Claim:
For the prevention of mastitis in cows after drying off and peri-calving mastitis in maiden heifers.
Use Claims Impacted by the Reassessment: - For the prevention of mastitis during the non-lactating (dry period) dairy cows and heifers (first calvers) with low individual somatic cell counts (first lactation <120,000 cells/mL; subsequent lactation <150,000 cells/mL) at drying off.
- For pre-calving administration in maiden heifers for the prevention of mastitis.
The applicant’s address for service is:
Bayer New Zealand Limited, 3 Argus Place, Hillcrest, Auckland 0627. Postal Address: PO Box 2825, Shortland Street, Auckland 1140.
Trade Name: drySeal
Reference: A011157
Active Ingredients and Concentrations:
- Bismuth subnitrate 650mg/g and PVP-iodine as a preservative 1mg/g per 4.0g syringe
Formulation Type: Intramammary suspension
General Use Claim:
For the prevention of mastitis during the non-lactating (dry) period in cows, and also heifers at the end of their first lactation.
Use Claims Impacted by the Reassessment: - For the prevention of mastitis during the non-lactating (dry) period in cows and heifers at the end of the first lactation with somatic cell counts (SCC) of less than 150,000 and 120,000 respectively.
- For the prevention of mastitis during the non-lactating (dry) period in cows and heifers with higher somatic cell counts (SCC) immediately following treatment with an appropriate antibiotic dry cow therapy.
The applicant’s address for service is:
Norbrook NZ Limited, KPMG Centre, 18 Viaduct Harbour Avenue, Auckland 1010. Postal Address: Norbrook Laboratories Australia Pty Limited, PO Box 189, Tullamarine, Australia.
Trade Name: Sureseal
Reference: A010866
Active Ingredient and Concentration:
- Bismuth subnitrate 650mg/g per 4.0g syringe
Formulation Type: Intramammary suspension
General Use Claim:
For the prevention of mastitis during the non-lactating (dry) period.
Use Claims Impacted by the Reassessment: - For the prevention of mastitis during the non-lactating (dry) period in lactating heifers (first calvers) and cows with somatic cell counts (SCC) of less than 120,000 and 150,000 respectively.
54
Next Page →
NZ Gazette 2016, No 72
✨ LLM interpretation of page content
🌾
Notice of Reassessment of Registered Trade Name Products
(continued from previous page)
🌾 Primary Industries & Resources12 August 2016
Agricultural Compounds, Veterinary Medicines, Reassessment, Intercept, drySeal, Sureseal, Mastitis Prevention